USTR Says Administration Supports TRIPS Waiver for Vaccines
U.S. Trade Representative Katherine Tai announced May 5 that the U.S. will support an intellectual property waiver for COVID-19 vaccines, but she cautioned that negotiating the language in Geneva will take time, because of both the need for consensus at…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
the World Trade Organization and the “complexity of the issues.” Top Democrats in Congress welcomed the announcement. Tai also said the administration will work to increase production of raw materials for vaccines.